Janelle Vu Pugashetti1, Dinesh Khanna2, Ella A Kazerooni3

  • 1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan.

概括

鉴定生物标志物对于诊断和预测患有间歇性肺病 (ILD) 并发症结合组织疾病 (CTD) 患者的结果至关重要. 本综述强调了CTD-ILD管理生物标志物的近期进展.